United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 4 minute read Pharma Industry News Atai Life Sciences acquires exclusive rights to Psilera’s DMT patent portfolio Atai Life Sciences has taken a strategic step in expanding its position in psychedelic medicine by securing exclusive… byPallavi MadhirajuFebruary 22, 2025